ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag chronic pain culture ecology

Capsule Reviews
Bob Grant | May 1, 2014 | 3 min read
Madness and Memory, Promoting the Planck Club, The Carnivore Way, and The Tale of the Dueling Neurosurgeons
The Little Cell That Could
Megan Scudellari | Jul 1, 2012 | 7 min read
Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.
Underground Supermodels
Thomas J. Park and Rochelle Buffenstein | Jun 1, 2012 | 10+ min read
What can a twentysomething naked mole-rat tell us about fighting pain, cancer, and aging?
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
The Proteasome: A Powerful Target for Manipulating Protein Levels
John Hines and Craig M. Crews | May 1, 2017 | 10+ min read
The proteasome’s ability to target and degrade specific proteins is proving useful to researchers studying protein function or developing treatments for diseases.
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
Syphilis: Then and Now
Kristin N Harper, George J. Armelagos, and Molly K. Zuckerman | Feb 1, 2014 | 10+ min read
Researchers are zeroing in on the origin of syphilis and related diseases, which continue to plague the human population some 500 years after the first documented case.
African Sleeping Sickness: A Recurring Epidemic
Ricki Lewis | May 12, 2002 | 5 min read
African trypanosomiasis is making an unwelcome comeback. But unlike other returning diseases, this one has a drug treatment—eflornithine—that disappeared from the market when it failed to cure cancer. Yet like Viagra's origin from a curious side effect in a clinical trial, so too was eflornithine reborn. "When it was discovered that it removes mustaches in women, it suddenly had a market: western women with mustaches," says Morten Rostrup, president of the international council for M
Have Science Training, Will Travel
Jennifer Fisher Wilson | Jun 10, 2001 | 9 min read
In the early 1990s, just after Operation Desert Storm, scientists from the Walter Reed Army Institute of Research traveled to the lower Amazon basin to conduct trials with a new antimalarial medication. They found an epidemic in full swing among a camp of gold miners. The scientists labored in the humidity of the tropical rain forest to set up a clinic. But rumors slowed their progress: People said the researchers planned to develop medications, not for Brazilians, but rather for U.S. forces who
What Price Salmon?
Steve Bunk | Jan 21, 2001 | 10+ min read
Credit: OAR/National Undersea Research Program (NURP) With the year-end release of a final decision on how to proceed toward saving wild Northwest salmon from extinction, the Clinton Administration left implementation of its long-awaited plan to the incoming Republicans. For years, researchers have struggled under a glare of media exposure to resolve a central issue: should four hydroelectric dams in Washington be removed to help save the fish? The conclusion is no, not yet, but a scientific div

Run a Search

ADVERTISEMENT